Terms: = Lymphoma AND FOXO3, FKHRL1, 2309, ENSG00000118689, MGC31925, MGC12739, FOXO2, FOXO3A, O43524, AF6q21, FKHRL1P2, DKFZp781A0677 AND Treatment
36 results:
1. Establishment of ganglioside GD2-expressing extranodal NK/T-cell lymphoma cell line with scRNA-seq analysis.
Sato S; Ishii M; Tachibana K; Furukawa Y; Toyota T; Kinoshita S; Azusawa Y; Ando J; Ando M
Exp Hematol; 2024 Feb; 130():104132. PubMed ID: 38029851
[TBL] [Abstract] [Full Text] [Related]
2. FKBP3 aggravates the malignant phenotype of diffuse large B-cell lymphoma by PARK7-mediated activation of Wnt/β-catenin signalling.
Xing X; Liu M; Wang X; Guo Q; Wang H; Wang W
J Cell Mol Med; 2024 Jan; 28(1):e18041. PubMed ID: 37987202
[TBL] [Abstract] [Full Text] [Related]
3. [Multiomics and Multidimensional Testing for Efficacy Monitoring of Patients with lymphoma].
Wang XH; Yang YX; Wang YJ; Yue BH; Zhang MZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):746-752. PubMed ID: 37356935
[TBL] [Abstract] [Full Text] [Related]
4. [Regulation of Baicalin on Growth of Extranodal NK/T Cell lymphoma Cells through foxo3/
Duan XH; Li H; Lyu Y; Liu J; Wang SX; Wu ZT; Wang BX; Lu M; Wang JH; Liang R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):730-738. PubMed ID: 37356933
[TBL] [Abstract] [Full Text] [Related]
5. The discrete roles of individual FOXO transcription factor family members in B-cell malignancies.
Lees J; Hay J; Moles MW; Michie AM
Front Immunol; 2023; 14():1179101. PubMed ID: 37275916
[TBL] [Abstract] [Full Text] [Related]
6. The CRL4
Tseng C; Han Y; Lv Z; Song Q; Wang K; Shen H; Chen Z
J Mol Med (Berl); 2023 Feb; 101(1-2):171-181. PubMed ID: 36688959
[TBL] [Abstract] [Full Text] [Related]
7. A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas.
Jang JY; Hwang I; Pan H; Yao J; Alinari L; Imada E; Zanettini C; Kluk MJ; Wang Y; Lee Y; Lin HV; Huang X; Di Liberto M; Chen Z; Ballman KV; Cantley LC; Marchionni L; Inghirami G; Elemento O; Baiocchi RA; Chen-Kiang S; Belvedere S; Zheng H; Paik J
J Clin Invest; 2022 Dec; 132(24):. PubMed ID: 36282572
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic and therapeutic significance of XPO1 in T-cell lymphoma.
Nie D; Xiao X; Chen J; Xie S; Xiao J; Yang W; Liu H; Wang J; Ma L; Du Y; Huang K; Li Y
Exp Cell Res; 2022 Jul; 416(2):113180. PubMed ID: 35489384
[TBL] [Abstract] [Full Text] [Related]
9. Downregulation of PUMA underlies resistance to FGFR1 inhibitors in the stem cell leukemia/lymphoma syndrome.
Liu Y; Cai B; Chong Y; Zhang H; Kemp CA; Lu S; Chang CS; Ren M; Cowell JK; Hu T
Cell Death Dis; 2020 Oct; 11(10):884. PubMed ID: 33082322
[TBL] [Abstract] [Full Text] [Related]
10. Iron chelation and 2-oxoglutarate-dependent dioxygenase inhibition suppress mantle cell lymphoma's cyclin D1.
Babosova O; Kapralova K; Raskova Kafkova L; Korinek V; Divoky V; Prchal JT; Lanikova L
J Cell Mol Med; 2019 Nov; 23(11):7785-7795. PubMed ID: 31517438
[TBL] [Abstract] [Full Text] [Related]
11. ALK positively regulates MYCN activity through repression of HBP1 expression.
Claeys S; Denecker G; Durinck K; Decaesteker B; Mus LM; Loontiens S; Vanhauwaert S; Althoff K; Wigerup C; Bexell D; Dolman E; Henrich KO; Wehrmann L; Westerhout EM; Demoulin JB; Kumps C; Van Maerken T; Laureys G; Van Neste C; De Wilde B; De Wever O; Westermann F; Versteeg R; Molenaar JJ; Påhlman S; Schulte JH; De Preter K; Speleman F
Oncogene; 2019 Apr; 38(15):2690-2705. PubMed ID: 30538293
[TBL] [Abstract] [Full Text] [Related]
12. Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastoma.
Emdal KB; Pedersen AK; Bekker-Jensen DB; Lundby A; Claeys S; De Preter K; Speleman F; Francavilla C; Olsen JV
Sci Signal; 2018 Nov; 11(557):. PubMed ID: 30459283
[TBL] [Abstract] [Full Text] [Related]
13. Idelalisib promotes Bim-dependent apoptosis through AKT/foxo3a in hepatocellular carcinoma.
Yue D; Sun X
Cell Death Dis; 2018 Sep; 9(10):935. PubMed ID: 30224718
[TBL] [Abstract] [Full Text] [Related]
14. Patient-Reported Outcomes Data From REVEAL at the Time of Enrollment (Baseline): A Prospective Observational Study of Patients With Polycythemia Vera in the United States.
Mesa R; Boccia RV; Grunwald MR; Oh ST; Colucci P; Paranagama D; Parasuraman S; Stein BL
Clin Lymphoma Myeloma Leuk; 2018 Sep; 18(9):590-596. PubMed ID: 30122202
[TBL] [Abstract] [Full Text] [Related]
15. 1α,25(OH) 2D3 Sensitive Cytosolic pH Regulation and Glycolytic Flux in Human Endometrial Ishikawa Cells.
Zeng N; Zhou Y; Zhang S; Singh Y; Shi B; Salker MS; Lang F
Cell Physiol Biochem; 2017; 41(2):678-688. PubMed ID: 28222424
[TBL] [Abstract] [Full Text] [Related]
16. PI3K-δ inhibition using CAL-101 exerts apoptotic effects and increases doxorubicin-induced cell death in pre-B-acute lymphoblastic leukemia cells.
Safaroghli-Azar A; Bashash D; Sadreazami P; Momeny M; Ghaffari SH
Anticancer Drugs; 2017 Apr; 28(4):436-445. PubMed ID: 28125433
[TBL] [Abstract] [Full Text] [Related]
17. Inhibition of telomerase using BIBR1532 enhances doxorubicin-induced apoptosis in pre-B acute lymphoblastic leukemia cells.
Bashash D; Zareii M; Safaroghli-Azar A; Omrani MD; Ghaffari SH
Hematology; 2017 Jul; 22(6):330-340. PubMed ID: 28054503
[TBL] [Abstract] [Full Text] [Related]
18. FOXO transcription factors in cancer development and therapy.
Coomans de Brachène A; Demoulin JB
Cell Mol Life Sci; 2016 Mar; 73(6):1159-72. PubMed ID: 26686861
[TBL] [Abstract] [Full Text] [Related]
19. Serine 574 phosphorylation alters transcriptional programming of foxo3 by selectively enhancing apoptotic gene expression.
Li Z; Zhao J; Tikhanovich I; Kuravi S; Helzberg J; Dorko K; Roberts B; Kumer S; Weinman SA
Cell Death Differ; 2016 Apr; 23(4):583-95. PubMed ID: 26470730
[TBL] [Abstract] [Full Text] [Related]
20. foxo3a and Posttranslational Modifications Mediate Glucocorticoid Sensitivity in B-ALL.
Consolaro F; Ghaem-Maghami S; Bortolozzi R; Zona S; Khongkow M; Basso G; Viola G; Lam EW
Mol Cancer Res; 2015 Dec; 13(12):1578-90. PubMed ID: 26376801
[TBL] [Abstract] [Full Text] [Related]
[Next]